Table 1.
Patient characteristics and study outcomes.
| Variable | Number of Patients (N = 47) |
|---|---|
| Patient demographics | |
| Age in years, mean ± SD | 51.5 ± 18.8 |
| Female | 27 (57.4) |
| Total number of oral drugs, mean ± SD | 8.0 ± 3.2 |
| Hospital location | |
| Medical wards | 29 (61.7) |
| Surgical wards | 7 (14.9) |
| Isolation unit | 8 (17.0) |
| Gynecology ward | 3 (6.4) |
| Indication | |
| Urinary tract infection | 18 (38.3) |
| Tuberculosis | 9 (19.1) |
| Skin and soft tissue infection | 6 (12.8) |
| Respiratory | 4 (8.5) |
| Intra-abdominal infection | 4 (8.5) |
| Other infections | 6 (12.8) |
| Oral antibiotic | |
| Ciprofloxacin | 29 (61.7) |
| Moxifloxacin | 12 (25.5) |
| Doxycycline | 6 (12.8) |
| Antibiotic administration daily frequency | |
| Once | 23 (48.9) |
| Twice | 24 (51.1) |
| Oral DTCC | |
| Iron-containing products | 28 (59.6) |
| Calcium-containing products | 15 (31.9) |
| Both iron- and calcium-containing products | 4 (8.5) |
| Iron-containing products daily administration frequency | |
| Once | 21 (44.7) |
| Twice | 11 (23.4) |
| Calcium-containing products daily administration frequency | |
| Once | 8 (17.0) |
| Twice | 7 (14.9) |
| Three times | 4 (8.5) |
| Study outcome | |
| Co-administration of antibiotics at the same time of DTCCs | 35 (74.5) |
| Co-administration of antibiotics with inappropriately separated DTCCs | 1 (2.1) |
Data are presented as number (%) unless otherwise indicated. DTCC: divalent or trivalent cation-containing compound.